Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction
Recruiting now · Not applicable
Conditions studied: Neurogenic Bowel Dysfunction, Spinal Cord Injury
In brief
The goal of this study is to test the safety and effectiveness of Vibrant capsules in spinal cord injury patients with neurogenic bowel.
Key facts
- Study ID
- NCT07213986
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 12
- Starts
- 2026-01-06
- Expected to finish
- 2026-08-19
- Last updated by the study team
- 2026-05-01
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individuals with chronic spinal cord injury (SCI) of more than one year.
- Stable neurological level and function of SCI for at least six months.
- Consistent bowel program without changes for at least 3 months.
- At least one scheduled bowel movement (BM) every three days.
- Use of digital stimulation, suppositories, enemas, or mini enemas, as part of the scheduled bowel program.
- Use of oral medications as part of the bowel program.
You may not qualify if…
- Bowel incontinence occurring more than once per week.
- Non-English-speaking individuals.
- History of bowel obstruction, ileus, diverticulitis, or bowel surgery for a disease (appendix removal is ok).
- Persistent autonomic dysreflexia (AD) triggered by bowel movements.
- Recent changes to spasticity medications within the past month.
- History of significant gastrointestinal disorders
- History of Zenker's diverticulum
- Dysphagia
- Esophageal stricture
- Eosinophilic esophagitis or achalasia
- Pregnancy.
- Presence of implanted devices that could be affected by proximity to a direct current magnetic field.
Where it is running
- TIRR Memorial Hermann — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.